Medication info

Metformin Tablet (Metformin Hydrochloride)

Prescription medicationTabletExpired
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 202001394 · Approved 2020.02.27

This product's status changed to Expired on 2025.02.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of type 2 diabetes mellitus
Who uses it
Adults · Children
Adult dosage
The dose should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, treatment with this medication must be initiated at a low dose: 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess the treatment response and determine the minimum effective dose. Glycated hemoglobin should be measured approximately every 3 months. The goal of treatment with this medication, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose glucose was controlled by diet alone, adequate efficacy may be achieved with short-term administration of this medication. This medication may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dosage adjustment. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, this medication must be discontinued immediately.
Children's dosage
Children aged 10 years or older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Blood glucose should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used in patients with type 2 diabetes whose blood sugar control is insufficient with diet and exercise alone, particularly in overweight adult patients. In adults, this medication can be used alone or in combination with other oral hypoglycemic agents or insulin. Additionally, it can be used in children and adolescents over the age of 10 as monotherapy or in combination with insulin. This medication helps control blood sugar and improves diabetes management.

Dosage and Administration

Adult dosage

The dose should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, treatment with this medication must be initiated at a low dose: 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess the treatment response and determine the minimum effective dose. Glycated hemoglobin should be measured approximately every 3 months. The goal of treatment with this medication, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose glucose was controlled by diet alone, adequate efficacy may be achieved with short-term administration of this medication. This medication may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dosage adjustment. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, this medication must be discontinued immediately.

Children's dosage

Children aged 10 years or older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Blood glucose should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, so caution should be exercised. It should particularly not be administered to patients with moderate to severe renal impairment, acute heart failure or myocardial infarction, or patients in a severe infection state. Additionally, before undergoing tests using iodine contrast agents, this medication should be discontinued and can only be restarted after reassessing renal function. It is contraindicated in patients with hypersensitivity to this medication, or in patients with type 1 diabetes or metabolic acidosis. The medication should be discontinued 48 hours before surgery and can only be restarted after confirming normal renal function. Caution is also necessary in patients with malnutrition or weakness, liver dysfunction, significant lung disease, or those who consume excessive alcohol. This medication may cause gastrointestinal symptoms, metallic taste, skin rash, and rarely anemia, decreased blood cells, abnormal liver function, and hypoglycemia; if any unusual symptoms appear, medical consultation should be sought immediately. Renal function should be monitored regularly, and caution is especially needed for the elderly or patients with impaired renal function. Alcohol consumption may increase the risk of side effects from this medication, so excessive drinking should be avoided. Furthermore, there may be interactions with other medications; be sure to inform healthcare professionals of any other medications taken, and the blood sugar control status should be closely monitored during treatment. During pregnancy or breastfeeding, this medication should be used cautiously based on the physician's judgment, and careful observation of its effects on the fetus or newborn is necessary. In cases of overdose, this medication can be removed by blood dialysis, so immediate emergency care should be sought if an overdose is suspected. This medication does not cause weight gain, which is advantageous for diabetes treatment, but regular monitoring of blood sugar and renal function, along with checking vitamin B12 levels, is required.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. This storage will help maintain the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.